ITPD920073A1 - Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali - Google Patents

Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Info

Publication number
ITPD920073A1
ITPD920073A1 IT000073A ITPD920073A ITPD920073A1 IT PD920073 A1 ITPD920073 A1 IT PD920073A1 IT 000073 A IT000073 A IT 000073A IT PD920073 A ITPD920073 A IT PD920073A IT PD920073 A1 ITPD920073 A1 IT PD920073A1
Authority
IT
Italy
Prior art keywords
phospholipids
contaminants
purification
mixtures
preparation
Prior art date
Application number
IT000073A
Other languages
English (en)
Inventor
Lanfranco Callegaro
Martino Alessandro Di
Gino Toffano
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITPD920073A priority Critical patent/IT1260149B/it
Publication of ITPD920073A0 publication Critical patent/ITPD920073A0/it
Priority to AT93911469T priority patent/ATE150025T1/de
Priority to EP93911469A priority patent/EP0638083B1/en
Priority to PCT/EP1993/000915 priority patent/WO1993021190A1/en
Priority to DE69308834T priority patent/DE69308834D1/de
Publication of ITPD920073A1 publication Critical patent/ITPD920073A1/it
Application granted granted Critical
Publication of IT1260149B publication Critical patent/IT1260149B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ITPD920073A 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali IT1260149B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
AT93911469T ATE150025T1 (de) 1992-04-17 1993-04-16 Verfahren zur herstellung und reinigung von phospholipidmischungen frei von kontaminierenden unkonventionellen viren
EP93911469A EP0638083B1 (en) 1992-04-17 1993-04-16 Method for the preparation and purification of phospholipid mixtures free from contamination by unconventional viruses
PCT/EP1993/000915 WO1993021190A1 (en) 1992-04-17 1993-04-16 Method for the preparation and purification of phospholipid mixtures free from contamination by unconventional viruses
DE69308834T DE69308834D1 (de) 1992-04-17 1993-04-16 Verfahren zur herstellung und reinigung von phospholipidmischungen frei von kontaminierenden unkonventionellen viren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Publications (3)

Publication Number Publication Date
ITPD920073A0 ITPD920073A0 (it) 1992-04-17
ITPD920073A1 true ITPD920073A1 (it) 1993-10-17
IT1260149B IT1260149B (it) 1996-03-28

Family

ID=11389905

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Country Status (5)

Country Link
EP (1) EP0638083B1 (it)
AT (1) ATE150025T1 (it)
DE (1) DE69308834D1 (it)
IT (1) IT1260149B (it)
WO (1) WO1993021190A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
FR2721516B1 (fr) * 1994-06-27 1996-09-13 Inst Rech Biolog Sa Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
FR2736265B1 (fr) * 1995-07-07 1997-09-26 Forgeot Marcel Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives
EP0888131B1 (fr) 1996-03-15 2002-04-03 Aventis Pasteur Procede pour eliminer les agents transmissibles non conventionnels d'une solution proteique
FR2746030B1 (fr) * 1996-03-15 1998-04-17 Procede pour eliminer les agents transmissibles non conventionnels (atnc) d'une solution d'albumine
FR2750887B1 (fr) * 1996-07-09 1998-10-23 Imedex Procede d'elimination des agents transmissibles non conventionnels (atnc) d'une solution proteique
JP4599604B2 (ja) * 2002-04-19 2010-12-15 カーギル テクスチュアライジング ソリューションズ ドイチュラント ゲゼルシャフト ミット ベシュレクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 生体活性のリン脂質含有成分を含有するマトリックス
DE10250727B4 (de) * 2002-04-19 2008-07-10 Cargill, Incorporated, Wayzata Matrix mit einer bioaktiven Phospholipid-haltigen Komponente
ITPD20050164A1 (it) * 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
WO2022190858A1 (ja) * 2021-03-12 2022-09-15 株式会社レオロジー機能食品研究所 歯周組織炎症改善用組成物
IT202100032252A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi
CN115010748B (zh) * 2022-05-27 2023-10-20 扬州大学 硅胶柱层析同时分离纯化磷脂酰胆碱和鞘磷脂的方法
CN114989212B (zh) * 2022-05-27 2024-11-05 广州白云山汉方现代药业有限公司 一种天然鞘磷脂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
ES528692A0 (es) * 1984-01-04 1985-07-01 Bioiberica Procedimiento para la obtencion de un complejo glicoesfingolipidico
IN171530B (it) * 1989-11-17 1992-11-07 Fidia Spa

Also Published As

Publication number Publication date
EP0638083B1 (en) 1997-03-12
WO1993021190A1 (en) 1993-10-28
EP0638083A1 (en) 1995-02-15
DE69308834D1 (de) 1997-04-17
IT1260149B (it) 1996-03-28
ATE150025T1 (de) 1997-03-15
ITPD920073A0 (it) 1992-04-17

Similar Documents

Publication Publication Date Title
ITPD920073A1 (it) Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
FI942095L (fi) Puhdistettuja hepariinifraktioita, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
ES2122218T3 (es) Procedimiento de separacion de una composicion polidispersada de sacaridos.
UA39135C2 (uk) Спосіб фракціонування розчину
KR950700779A (ko) 단백질의 정제방법(Protein purification)
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
PT731812E (pt) Metodo para isolar poli-beta-1-4-n-acetilglucosamina
NO308029B1 (no) Inhibitorer av <beta>-amyloidproteinproduksjon og farmasøytisk preparat inneholdende disse
BR8605129A (pt) Processo para purificacao de uma proteina atraves de cromatografia de coluna e processo para purificar fator anti-hemofilico a partir de crioprecipitado de plasma
BR9810002A (pt) Preparação de <244>1-at nativa purificada cromatograficamente, processo para a preparação da mesma, e, utilização de um material de suporte
BR0209081A (pt) Processo de remoção de produto e sistema de remoção de produto in situ
BR122012018280B8 (pt) composição farmacêutica compreendendo hormônio luteinizante humano e sacarose
KR880003975A (ko) 항응고성 및 항전이성을 갖는 단백질
ATE509028T1 (de) Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
ES2169384T3 (es) Procedimiento cromatografico para la obtencion de ciclosporina a altamente purificada y ciclosporinas analogas.
ATE207930T1 (de) Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt
Zlotkin et al. A protein toxic to crustacea from the venom of the scorpion Androctonus australis
PT82319B (pt) Processo de preparacao de derivados de indeno e de naftaleno e de composicoes farmceuticas que os contem
BR0212260A (pt) Agente antimicrobiano
DK0396022T3 (da) Fremgangsmåde til isolering af blodkoagulationsfaktor IX
Hearn et al. The Analysis of Insulin-Related Peptides by Reversed-Phase High-Performance Liquid Chromatography
Araujo et al. Potentiation of bradykinin action on smooth muscle by a scorpion venom extract
ES2111105T3 (es) Procedimiento analitico para la verificacion de componentes toxicos de mezclas.
Tillement et al. Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro
Dergunov et al. Heparin-sepharose affinity chromatography and reduction conditions as a method of a selective process for separate isoforms of apolipoprotein A

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970131